LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2004 | -14.2 Million USD | 4.34% |
| 2003 | -14.84 Million USD | -21.08% |
| 2002 | -12.26 Million USD | -67.24% |
| 2001 | -7.33 Million USD | -84.86% |
| 2000 | -3.96 Million USD | -52.49% |
| 1999 | -2.6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2005 Q3 | -2.27 Million USD | -7.32% |
| 2005 Q1 | -1.99 Million USD | 80.6% |
| 2005 Q2 | -2.12 Million USD | -6.2% |
| 2004 FY | - USD | 4.34% |
| 2004 Q4 | -10.3 Million USD | -752.66% |
| 2004 Q3 | -1.2 Million USD | 83.27% |
| 2004 Q2 | -7.22 Million USD | -414.71% |
| 2004 Q1 | -1.4 Million USD | 73.58% |
| 2003 Q2 | -3.76 Million USD | -21.15% |
| 2003 Q4 | -5.31 Million USD | -99.16% |
| 2003 Q1 | -3.1 Million USD | 19.96% |
| 2003 Q3 | -2.66 Million USD | 29.07% |
| 2003 FY | - USD | -21.08% |
| 2002 Q4 | -3.87 Million USD | -29.97% |
| 2002 Q3 | -2.98 Million USD | 0.77% |
| 2002 Q1 | -2.39 Million USD | -8.49% |
| 2002 Q2 | -3 Million USD | -25.76% |
| 2002 FY | - USD | -67.24% |
| 2001 FY | - USD | -84.86% |
| 2001 Q4 | -2.2 Million USD | -17.87% |
| 2001 Q3 | -1.87 Million USD | -9.4% |
| 2001 Q2 | -1.7 Million USD | -10.41% |
| 2001 Q1 | -1.54 Million USD | -22.51% |
| 2000 Q1 | -811.54 Thousand USD | 0.0% |
| 2000 Q2 | -994.88 Thousand USD | -22.59% |
| 2000 Q3 | -1 Million USD | -1.0% |
| 2000 Q4 | -1.26 Million USD | -25.77% |
| 2000 FY | - USD | -52.49% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -1373.321% |
| Ansell Limited | 209.86 Million USD | 106.767% |
| Ansell Limited | 206.3 Million USD | 106.884% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 133.152% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | -774.004% |
| Psykey, Inc. | -1.29 Million USD | -996.433% |
| ConvaTec Group Plc | 455.5 Million USD | 103.118% |
| ConvaTec Group Plc | 455.5 Million USD | 103.118% |
| Encision Inc. | -544.19 Thousand USD | -2509.751% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -9914.905% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -12819.255% |
| Innovative MedTech Inc. | -7.67 Million USD | -85.073% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | -129.548% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -4269.888% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -6498.464% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -3399.925% |
| SmileDirectClub, Inc. | -186.13 Million USD | 92.37% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 103.171% |
| SheerVision, Inc. | -110.53 Thousand USD | -12749.008% |
| United Health Products, Inc. | -2.5 Million USD | -467.583% |
| Vasamed, Inc. | -4.57 Million USD | -210.467% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | -528.209% |
| Yubo International Biotech Limited | -1.17 Million USD | -1105.936% |